Article
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Nov 2021
Hamilton Jada G, Symecko Heather, Spielman Kelsey, Breen Kelsey, Mueller Rebecca, Catchings Amanda, Trottier Magan, Salo-Mullen Erin E, Shah Ibrahim, Arutyunova Anna, Batson Melissa, Gebert Rebecca, Pundock Stacy, Schofield Elizabeth, Offit Kenneth, Stadler Zsofia K, Cadoo Karen, Carlo Maria I, Narayan Vivek, Reiss Kim A, Robson Mark E, Domchek Susan M
Abstract excerpt
PURPOSE: To address demands for timely germline information to guide treatments, we evaluated experiences of patients with ovarian, pancreatic, and prostate cancer with a mainstreaming genetic testing model wherein multigene panel testing was ordered by oncologists with standardized pretest patient education, and genetic counselors delivered results and post-test genetic counseling via telephone. METHODS: Among...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
